XBiotech Inc. (XBIT) Financials

XBIT Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 227.2 million 8.4 million
2023-09-30 229.6 million 6.9 million
2023-06-30 235.1 million 6.1 million
2023-03-31 242.1 million 5.2 million

XBIT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -3.5 million 688000
2023-09-30 -1.5 million 955000
2023-06-30 -9.2 million 914000
2023-03-31 -4.8 million 705000

XBIT Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 -4.6 million
2023-09-30 -7.4 million
2023-06-30 -8.7 million
2023-03-31 -3.8 million

XBIT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 200.0 million - -
2023-09-30 202.2 million - -
2023-06-30 204.8 million - -
2023-03-31 212.7 million - -

XBIT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 30.4 million
2023-09-30 30.4 million
2023-06-30 30.4 million
2023-03-31 30.4 million

XBIT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 115000 7.8 million 783000 434000
2023-09-30 33000 7.5 million 973000 -
2023-06-30 208000 11.3 million 2.0 million -
2023-03-31 6000 6.2 million 915000 -

XBIT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 434000
2023-09-30 - 432000
2023-06-30 - 435000
2023-03-31 - 443000

XBIT

Price: $8.67

52 week price:
3.05
9.89

Payout Ratio Range:
-290.70%
1923.08%

Earnings Per Share: -0.81 USD

P/E Ratio: -7.22

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 35800

Ebitda: -47.9 million

Market Capitalization: 250.0 million

Links: